2020-11-16T15:46:36-06:00 2019-12-31 841158905 CAUSEY DEMGEN & MOORE PC 1099 18TH ST SUITE 2300 DENVER CO 802021939 990 2019-01-01 200499338 INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER INTE 7203252948 999 17TH STREET SUITE 200 DENVER CO 802022725 JOHN SKADOW CFO 7203252948 2020-11-16 1 JAMEY CAMP-CAVANAUGH P01382513 3032962229 38.140.32.146 2020-11-16 13:11:34 MS P EE0FD4D84A20D749F3B3570C0DCFF9AD3A7F306A 1B8B985CAF0AA3361A428787D463125CBB4DC13B 2019 2021-01-29 14:40:06Z X JOHN SKADOW 999 17TH ST SUITE 200 DENVER CO 802022725 18805451 0 X WWW.IASLC.ORG X 2003 CO TO PROMOTE THE STUDY OF THE ETIOLOGY, EPIDEMIOLOGY, PREVENTION, DIAGNOSIS, TREATMENT AND ALL OTHER ASPECTS OF LUNG CANCER AND OTHER THORACIC MALIGNANCIES.TO PROVIDE EDUCATION AND INFORMATION ABOUT LUNG CANCER AND OTHER THORACIC MALIGNANCIES TO IASLC MEMBERS, TO THE MEDICAL COMMUNITY AT LARGE, AND TO THE PUBLIC.TO USE ALL AVAILABLE MEANS TO ELIMINATE LUNG CANCER AND OTHER THORACIC MALIGNANCIES AS A HEALTH THREAT FOR THE INDIVIDUAL PATIENT AND THROUGHOUT THE WORLD. 16 16 30 0 0 0 763425 836129 13551881 16912007 -303133 1052162 10271 5153 14022444 18805451 128195 629924 0 0 2659631 3065894 0 0 404775 11704519 14134875 14492345 17830693 -469901 974758 18205297 21412257 4275893 6365618 13929404 15046639 X TO PROMOTE THE STUDY OF THE ETIOLOGY, EPIDEMIOLOGY, PREVENTION, DIAGNOSIS, TREATMENT AND ALL OTHER ASPECTS OF LUNG CANCER AND OTHER THORACIC MALIGNANCIES.TO PROVIDE EDUCATION AND INFORMATION ABOUT LUNG CANCER AND OTHER THORACIC MALIGNANCIES TO IASLC MEMBERS, TO THE MEDICAL COMMUNITY AT LARGE, AND TO THE PUBLIC.TO USE ALL AVAILABLE MEANS TO ELIMINATE LUNG CANCER AND OTHER THORACIC MALIGNANCIES AS A HEALTH THREAT FOR THE INDIVIDUAL PATIENT AND THROUGHOUT THE WORLD. 0 0 1217670 629924 1153586 MEMBERSHIPS, SCIENTIFIC AND OTHER PROGRAMS TO ADVANCE THE STUDY OF LUNG CANCER 3855606 1081821 PUBLICATIONS-PROVIDE EDUCATION TO THE WORLD WIDE LUNG CANCER COMMUNITY REGARDING THE LATEST ADVANCES IN LUNG CANCER TREATMENT. 10404779 5601516 MEETING AND WEB SEMINARS TO DISSEMINATE INFORMATION REGARDING THE LATEST ADVANCES IN LUNG CANCER TREATMENT. 15478055 1 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 0 1 0 0 1 0 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 30 0 1 30 1 0 0 0 0 0 0 0 0 0 0 X 16 16 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 0 0 1 1 0 CO X JOHN SKADOW CFO 7203252948 999 17TH STREET SUITE 200 DENVER CO 802022725 X SURESH RAMALINGAM MD TREASURER 10.00 X 0 0 0 GIORGIO SCAGLIOTTI MD PHD PAST PRESIDENT 10.00 X 0 0 0 TETSUYA MITSUDOMI MD PHD PRESIDENT 10.00 X 0 0 0 HEATHER WAKELEE MD PRESIDENT ELECT 3.00 X 0 0 0 JULIE BRAHMER MD DIRECTOR 3.00 X 0 0 0 ANDREA BEZJAK MD DIRECTOR 3.00 X 0 0 0 ROY HERBST MD DIRECTOR 3.00 X 0 0 0 ENRIQUETA FELIP PHD SECRETARY 3.00 X 0 0 0 NIR PELED PHD DIRECTOR 3.00 X 0 0 0 ERIK THUNNISSE MD DIRECTOR 3.00 X 0 0 0 PAUL VAN SCHIL MD DIRECTOR 3.00 X 0 0 0 CAICUN ZHOU PHD DIRECTOR 3.00 X 0 0 0 JAMES YANG MD PHD DIRECTOR 3.00 X 0 0 0 MASAYUKI NOGUCHI MD DIRECTOR 3.00 X 0 0 0 CLARISSA MATHIAS MD DIRECTOR 3.00 X 0 0 0 YUKO NAKAYAMA MD DIRECTOR 3.00 X 0 0 0 DAVID MESKO CEO 40.00 X 331650 0 112677 ANNMARIE PRIEST DEVELOPMENT OFFICER 40.00 X 166600 0 56647 KRISTIN RICHEIMER DIRECTOR OF EXPERIENCE 40.00 X 166350 0 56562 JOHN SKADOW DIRECTOR OF FINANCE 40.00 X 155100 0 52737 MURRY WYNES DIRECTOR OF SCIENTIFIC AFF 40.00 X 160692 0 54730 980392 0 333353 8 0 1 0 FAIRMONT HOTEL 101 WILSHIRE BLVD SANTA MONICA CA 90401 CONFERENCE HOTEL 718084 CANCER RESEARCH & BIOSTATISTICS 1505 WESTLAKE AVENUE N STE 750 SEATTLE WA 98109 STATISTICIANS FOR PROJECTS 589157 INTERNATIONAL CONFERENCE SERVICES 1201 W PENDER ST STE 300 VANCOUVER BC CA V6E 2V2 CONFERENCE MANAGEMENT SERVICES 575579 FIRA BARCELONA AV REINA M CRISTINA BARCELOMA SPAIN SP 08004 TRADE FAIR ORGANIZATION 491487 DAVIS GRAHAM & STUBBS LLP 1550 17TH ST 500 DENVER CO 80202 LEGAL SERVICES 270248 5 836129 836129 MEETING INCOME 541900 12799973 5601516 7198457 SCIENTIFIC PROJECTS 541900 2222483 819836 1402647 PUBLICATIONS 541900 1550801 1081821 468980 WEB SEMINARS 541900 338750 333750 5000 16912007 191576 191576 5153 0 5153 5153 5153 860586 0 860586 860586 860586 18805451 7836923 0 10132399 455838 455838 174086 174086 1313745 444420 869325 1752149 1495730 256419 118258 118258 30000 30000 53660 53660 251961 154553 75160 22248 484948 297467 144660 42821 208423 132036 58942 17445 259710 69890 146465 43355 9505561 9175404 330157 147051 93127 41616 12308 SCIENTIFIC PROGRAMS 1568651 1568651 PUBLICATIONS 946794 946794 WEB SEMINARS 145891 145891 EDUCATION 134903 134903 279064 189265 79620 10179 17830693 15478055 1947863 404775 7925540 8922373 1009 3183809 3320275 1011290 310346 1599465 708435 664035 891030 5419614 7968233 18205297 21412257 554584 2603906 3359311 3761712 361998 0 4275893 6365618 X 13929404 15046639 13929404 15046639 18205297 21412257 X 974758 142478 -1 X X 0 1 X 1 0 X 784563 1047714 1251701 763425 836129 4683532 13879388 13911465 13083848 13551881 16912007 71338589 14663951 14959179 14335549 14315306 17748136 76022121 0 0 0 76022121 151809 202124 347114 -292863 1057314 1465498 151809 202124 347114 -292863 1057314 1465498 14815760 15161303 14682663 14022443 18805450 77487619 0.98110 0.99130 0.01890 0.00870 X 0 498052 185551 312501 455434 375076 80358 645979 147808 498171 891030 OTHER SECURITIES 7968233 F 7968233 X PART X, LINE 2: THE ASSOCIATION HAS ADOPTED GUIDANCE ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. AFTER EVALUATING THE TAX POSITIONS TAKEN, NONE ARE CONSIDERED TO BE UNCERTAIN; THEREFORE, NO AMOUNTS HAVE BEEN RECOGNIZED AS OF DECEMBER 31, 2018 AND 2019. THE ASSOCICATION IS NO LONGER SUBJECT TO U.S. FEDERAL INCOME TAX EXAMINATIONS FOR YEARS PRIOR TO 2015. 1 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 PROGRAM SERVICES SCIENTIFIC CONFERENCE 6971510 NORTH AMERICA - CANADA AND MEXICO, BUT NOT THE UNITED STATES 0 0 PROGRAM SERVICES SCIENTIFIC CONFERENCE 690768 0 0 0 0 0 0 7662278 0 7662278 THE IASLC OFFERS A VARIETY OF TRAVEL AWARDS TO HELP RESEARCHERS FROM AROUND THE WORLD ATTEND THE ANNUAL IASLC WORLD CONFERENCE ON LUNG CANCER. APPLICATIONS ARE ACCEPTED EACH YEAR, AND THE WINNERS ARE DETERMINED BY AN INTERNATIONAL MULTIDISCIPLINARY REVIEW COMMITTEE COMPRISED OF IASLC MEMBERS. EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, 34 62402 THE IASLC OFFERS A VARIETY OF TRAVEL AWARDS TO HELP RESEARCHERS FROM AROUND THE WORLD ATTEND THE ANNUAL IASLC WORLD CONFERENCE ON LUNG CANCER. APPLICATIONS ARE ACCEPTED EACH YEAR, AND THE WINNERS ARE DETERMINED BY AN INTERNATIONAL MULTIDISCIPLINARY REVIEW COMMITTEE COMPRISED OF IASLC MEMBERS. EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIU 7 10909 THE IASLC OFFERS A VARIETY OF TRAVEL AWARDS TO HELP RESEARCHERS FROM AROUND THE WORLD ATTEND THE ANNUAL IASLC WORLD CONFERENCE ON LUNG CANCER. APPLICATIONS ARE ACCEPTED EACH YEAR, AND THE WINNERS ARE DETERMINED BY AN INTERNATIONAL MULTIDISCIPLINARY REVIEW COMMITTEE COMPRISED OF IASLC MEMBERS. SOUTH AMERICA - ARGENTINA, BOLIVIA, BRAZIL, CHILE, COLUMBIA, ECUADOR, 221 100776 0 0 0 0 0 0 PART I, LINE 2: 1. GRANTS WILL BE INITIALLY REVIEWED BY THE COMMITTEE CHAIR FOR COMPLETENESS. INCOMPLETE SUBMISSIONS OR GRANTS SUBMITTED AFTER THE DEADLINE WILL BE RETURNED TO THE PI IN 48 HOURS. 2. EACH MEMBER OF THE SCIENTIFIC REVIEW COMMITTEE WILL RIGOROUSLY REVIEW THE APPLICATIONS. APPLICATIONS WILL BE SCORED ON FOUR CRITERIA: A. POTENTIAL OF THE CANDIDATE: IS THE CANDIDATE COMMITTED TO A CAREER IN LUNG CANCER RESEARCH? DOES THE CANDIDATE HAVE BASIC TRAINING RELATED TO THE PROJECT PROPOSED? PUBLISHED/SUBMITTED PAPERS OR ABSTRACTS CURRENT OR PENDING GRANT SUBMISSIONS STRONG LETTERS OF SUPPORT B. SCIENTIFIC MERIT OF THE PROJECT: IS THE PROPOSAL ORIGINAL? IS THE PROPOSAL CLEAR & CONCISE? ARE THE SPECIFIC AIMS REASONABLE? IS THE METHODOLOGY REASONABLE TO ACCOMPLISH THE OBJECTIVES? CAN THE PROJECT BY COMPLETED IN THE 2 YEAR TIME FRAME? C. SIGNIFICANCE OF PROJECT: IS THE PROJECT WITHIN THE IASLC SCOPE? WHAT WILL THIS INFORMATION CONTRIBUTE TO KNOWLEDGE IN THIS FIELD? DO THESE RESULTS SIGNIFICANTLY IMPROVE THE APPLICATION OF KNOWLEDGE OF LUNG CANCER? WILL THESE DATA STIMULATE FURTHER SCIENTIFIC RESEARCH INTO LUNG CANCER? D. STRENGTH OF THE PI/INSTITUTIONAL SUPPORT (FOR FELLOWSHIP GRANTS): IS THE PI DEDICATED TO ASSISTING IN THE EXECUTION AND COMPLETION OF THE PROJECT? IS THE PI OF GOOD STANDING IN THE FIELD OF LUNG CANCER RESEARCH? DOES THE PI HAVE SUFFICIENT GRANT SUPPORT FOR THE FELLOW TO COMPLETE THE PROJECT IF REQUIRED? DOES THE INSTITUTION HAVE THE NECESSARY RESOURCES TO SUPPORT THE PROJECT? SCORES WILL RANGE FROM 1-5. 5 - OUTSTANDING 4 - EXCELLENT 3 - GOOD 2 - POOR 1 - UNACCEPTABLE TOTAL SCORES WILL THEN BE TABULATED, AVERAGED, AND THE CANDIDATE RANKED. THE COMMITTEE WILL MEET BY CONFERENCE CALL TO SELECT THE AWARDEES. 3. PROGRESS REPORTS FROM YEAR 1 WILL BE REVIEWED BY THE COMMITTEE CHAIR. PART III ACCOUNTING METHOD: 1 IASLC OFFERS A VARIETY OF TRAVEL AWARDS TO HELP RESEARCHERS FROM AROUND THE WORLD ATTEND THE ANNUAL IASLC WORLD CONFERENCE ON LUNG CANCER. APPLICATIONS ARE ACCEPTED EACH YEAR, AND THE WINNERS ARE DETERMINED BY AN INTERNATIONAL MULTIDISCIPLINARY REVIEW COMMITTEE COMPRISED OF IASLC MEMBERS. 13 455838 1 X X X 0 0 0 0 0 0 0 0 0 DAVID MESKO CEO 331650 0 0 0 0 0 0 0 112677 0 444327 0 0 0 ANNMARIE PRIEST DEVELOPMENT OFFICER 156600 0 10000 0 0 0 0 0 56647 0 223247 0 0 0 KRISTIN RICHEIMER DIRECTOR OF EXPERIENCE 156350 0 10000 0 0 0 0 0 56562 0 222912 0 0 0 JOHN SKADOW DIRECTOR OF FINANCE 150100 0 5000 0 0 0 0 0 52737 0 207837 0 0 0 MURRY WYNES DIRECTOR OF SCIENTIFIC AFF 158192 0 2500 0 0 0 0 0 54730 0 215422 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B FOR 2019, THE CEO & CFO WILL REVIEW THE RETURN PRIOR TO THE FILING OF FORM 990. THE TAX RETURN WILL BE AVAILABLE TO THE BOARD AND FINANCE COMMITTEE FOR REVIEW FOLLOWING THE FILING OF FORM 990. FORM 990, PART VI, SECTION B, LINE 12C THROUGH YEARLY REVIEWS FORM 990, PART VI, SECTION B, LINE 15 THROUGH YEARLY REVIEWS FORM 990, PART VI, SECTION C, LINE 19 AVAILABLE UPON REQUEST FORM 990, PART XI, LINE 9: ROUNDING -1. PART XII, LINE 2C NO CHANGES TO PROCEDURES IN CURRENT YEAR